Business Description
Nanjing Vazyme Biotech Co Ltd
ISIN : CNE100004ZK3
Share Class Description:
SHSE:688105: Class ACompare
Compare
Traded in other countries / regions
688105.China IPO Date
2021-11-15Description
Nanjing Vazyme Biotech Co Ltd is a biotechnology company. It is committed to research and development both in technology and products focusing on functional proteins, such as enzymes, antigens, antibodies, and polymer organic materials.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.75 | |||||
| Equity-to-Asset | 0.8 | |||||
| Debt-to-Equity | 0.17 | |||||
| Debt-to-EBITDA | 42.99 | |||||
| Interest Coverage | 1.27 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 7.01 | |||||
| Beneish M-Score | -1.29 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -9.5 | |||||
| 3-Year EBITDA Growth Rate | -58.5 | |||||
| 3-Year Book Growth Rate | 39.6 | |||||
| Future 3-5Y Total Revenue Growth Rate | 21.38 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 19.13 | |||||
| 9-Day RSI | 30.87 | |||||
| 14-Day RSI | 39.48 | |||||
| 6-1 Month Momentum % | 15.35 | |||||
| 12-1 Month Momentum % | -23.87 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.69 | |||||
| Quick Ratio | 4.17 | |||||
| Cash Ratio | 3.38 | |||||
| Days Inventory | 330.5 | |||||
| Days Sales Outstanding | 104.27 | |||||
| Days Payable | 110.18 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.56 | |||||
| Dividend Payout Ratio | 0.59 | |||||
| Forward Dividend Yield % | 0.56 | |||||
| 5-Year Yield-on-Cost % | 0.56 | |||||
| 3-Year Average Share Buyback Ratio | -3.6 | |||||
| Shareholder Yield % | 2.09 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 70.71 | |||||
| Operating Margin % | 2.82 | |||||
| Net Margin % | 1.68 | |||||
| FCF Margin % | 0.48 | |||||
| ROE % | 0.59 | |||||
| ROA % | 0.44 | |||||
| ROIC % | -2.21 | |||||
| ROC (Joel Greenblatt) % | 1.18 | |||||
| ROCE % | 0.37 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 404.21 | |||||
| Forward PE Ratio | 42.93 | |||||
| PE Ratio without NRI | 136.33 | |||||
| PS Ratio | 6.14 | |||||
| PB Ratio | 2.34 | |||||
| Price-to-Tangible-Book | 2.48 | |||||
| Price-to-Free-Cash-Flow | 390.49 | |||||
| Price-to-Operating-Cash-Flow | 98.48 | |||||
| EV-to-EBIT | 486.78 | |||||
| EV-to-EBITDA | 486.78 | |||||
| EV-to-Revenue | 5.33 | |||||
| EV-to-FCF | 1120.68 | |||||
| Price-to-Graham-Number | 3.88 | |||||
| Price-to-Net-Current-Asset-Value | 3.73 | |||||
| Price-to-Net-Cash | 6.08 | |||||
| Earnings Yield (Greenblatt) % | 0.21 | |||||
| FCF Yield % | 0.07 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Nanjing Vazyme Biotech Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,402.604 | ||
| EPS (TTM) (Â¥) | 0.057 | ||
| Beta | 1.87 | ||
| Volatility % | 52.26 | ||
| 14-Day RSI | 39.48 | ||
| 14-Day ATR (Â¥) | 0.842163 | ||
| 20-Day SMA (Â¥) | 24.212 | ||
| 12-1 Month Momentum % | -23.87 | ||
| 52-Week Range (Â¥) | 16.85 - 32.88 | ||
| Shares Outstanding (Mil) | 402.13 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Nanjing Vazyme Biotech Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Nanjing Vazyme Biotech Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Nanjing Vazyme Biotech Co Ltd Frequently Asked Questions
What is Nanjing Vazyme Biotech Co Ltd(SHSE:688105)'s stock price today?
The current price of SHSE:688105 is ¥23.04. The 52 week high of SHSE:688105 is ¥32.88 and 52 week low is ¥16.85.
When is next earnings date of Nanjing Vazyme Biotech Co Ltd(SHSE:688105)?
The next earnings date of Nanjing Vazyme Biotech Co Ltd(SHSE:688105) is .
Does Nanjing Vazyme Biotech Co Ltd(SHSE:688105) pay dividends? If so, how much?
The Dividend Yield %  of Nanjing Vazyme Biotech Co Ltd(SHSE:688105) is 0.56% (As of Today), Highest Dividend Payout Ratio of Nanjing Vazyme Biotech Co Ltd(SHSE:688105) was 0.59. The lowest was 0.2. And the median was 0.2. The  Forward Dividend Yield % of Nanjing Vazyme Biotech Co Ltd(SHSE:688105) is 0.56%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers